Literature DB >> 3085135

Associative factors in the effects of morphine on self-stimulation.

T H Hand, K B Franklin.   

Abstract

These experiments tested the hypothesis that the suppressing and facilitating effects of morphine on intracranial self-stimulation (ICS) (measured 1 h and 3 h post-injection, respectively) are influenced by associative, non-pharmacological factors. Experiment 1 confirmed previous demonstrations that the facilitation of ICS by morphine (10 mg/kg) develops with repeated drug exposures. Once ICS facilitation had developed, the effect was mimicked by saline injection in most subjects. In a separate group of animals, previous exposure to morphine in the home cage prevented drug-induced facilitation of ICS. Tolerance to ICS suppression developed after repeated pairings of the drug and the ICS chambers, but not when the drug had previously been received in the home cage. Experiment 2 examined the effect of low (0.3, 1, 3 mg/kg) doses of chronic morphine on ICS. Facilitation was observed with 1 and 3 mg/kg, but only after repeated testing. Naloxone (0.1 and 1 mg/kg) failed to reverse facilitation in a number of these subjects. In Experiment 3, animals receiving their daily injections of morphine were allowed to self-stimulate only at 3 h post-injection (when ICS facilitation is usually maximal), rather than at 1 h and 3 h post-injection. ICS facilitation was not observed, even with repeated testing. These data indicate that the facilitation of ICS by morphine is the outcome of a learned association between drug administration and the ICS procedure, rather than the invariable result of opiate receptor activation. Repeated exposure to morphine is required for the initial establishment of ICS enhancement, but the subsequent expression of this behavior is not directly related to opiate receptor activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3085135     DOI: 10.1007/bf00178509

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  45 in total

1.  Conditioned temperature effects using morphine as the unconditioned stimulus.

Authors:  R Eikelboom; J Stewart
Journal:  Psychopharmacology (Berl)       Date:  1979-03-14       Impact factor: 4.530

2.  Effects of heroin on lever pressing for intracranial self-stimulation, food and water in the rat.

Authors:  G F Koob; N H Spector; J L Meyerhoff
Journal:  Psychopharmacologia       Date:  1975-06-19

3.  The temperature response in rats during acute and chronic morphine administration, a study of morphine tolerance.

Authors:  L M GUNNE
Journal:  Arch Int Pharmacodyn Ther       Date:  1960-12-31

4.  Sensitization to the behavioral effects of cocaine: modification by Pavlovian conditioning.

Authors:  R E Hinson; C X Poulos
Journal:  Pharmacol Biochem Behav       Date:  1981-10       Impact factor: 3.533

5.  A portrait of the substrate for self-stimulation.

Authors:  C R Gallistel; P Shizgal; J S Yeomans
Journal:  Psychol Rev       Date:  1981-05       Impact factor: 8.934

6.  Dissociation of the rewarding and physical dependence-producing properties of morphine.

Authors:  M A Bozarth; R A Wise
Journal:  NIDA Res Monogr       Date:  1983-04

7.  Anatomically distinct opiate receptor fields mediate reward and physical dependence.

Authors:  M A Bozarth; R A Wise
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

8.  The relationship between pharmacokinetics and pharmacodynamic action as applied to in vivo pA2: application to the analgesic effect of morphine.

Authors:  R J Tallarida; C Harakal; J Maslow; E B Geller; M W Adler
Journal:  J Pharmacol Exp Ther       Date:  1978-07       Impact factor: 4.030

9.  Comparison of the effects of morphine on hypothalamic and medial frontal cortex self-stimulation in the rat.

Authors:  S A Lorens
Journal:  Psychopharmacology (Berl)       Date:  1976-07-28       Impact factor: 4.530

10.  Evidence that stress augments morphine analgesia by increasing brain tryptophan.

Authors:  S J Kelly; K B Franklin
Journal:  Neurosci Lett       Date:  1984-02-24       Impact factor: 3.046

View more
  8 in total

Review 1.  Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

Authors:  S Stevens Negus; Megan J Moerke
Journal:  Peptides       Date:  2018-11-01       Impact factor: 3.750

2.  The effect of morphine dependence on impulsive choice in rats.

Authors:  Colin Harvey-Lewis; Johnna Perdrizet; Keith B J Franklin
Journal:  Psychopharmacology (Berl)       Date:  2012-05-16       Impact factor: 4.530

3.  Pharmacological effects of morphine on brain-stimulation reward.

Authors:  S E Izenwasser; C Kornetsky
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Adolescent morphine exposure induces immediate and long-term increases in impulsive behavior.

Authors:  Parisa Moazen; Hossein Azizi; Hamed Salmanzadeh; Saeed Semnanian
Journal:  Psychopharmacology (Berl)       Date:  2018-10-23       Impact factor: 4.530

5.  Effects of pain- and analgesia-related manipulations on intracranial self-stimulation in rats: further studies on pain-depressed behavior.

Authors:  Gail Pereira Do Carmo; Glenn W Stevenson; William A Carlezon; S Stevens Negus
Journal:  Pain       Date:  2009-05-10       Impact factor: 6.961

6.  Differential mechanisms in the acquisition and expression of heroin-induced place preference.

Authors:  T H Hand; L Stinus; M Le Moal
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Preclinical Abuse Potential Assessment of Flibanserin: Effects on Intracranial Self-Stimulation in Female and Male Rats.

Authors:  Matthew F Lazenka; Bruce E Blough; S Stevens Negus
Journal:  J Sex Med       Date:  2016-01-28       Impact factor: 3.802

Review 8.  Rhythm and blues. Neurochemical, neuropharmacological and neuropsychological implications of a hypothesis of circadian rhythm dysfunction in the affective disorders.

Authors:  D Healy
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.